Modified cancer drug effective against multi-resistant bacteria

Antibiotic-resistant bacteria are increasingly the source of deadly infections. A team of scientists from the Technical University of Munich (TUM) and the Helmholtz Center for Infection Research (HZI) in Braunschweig have ...

Bacteria 'launch a shield' to resist attack

Bacteria that cause chronic lung infections can communicate with each other to form a deadly shield against the body's natural defenses. Studying these interactions could lead to new ways of treating bacteria that are resistant ...

Rapid identification of superbugs and new drugs to combat them

(Phys.org) -- Synthetic biology is playing a key role in creating new tools for rapid detection of potentially fatal bacterial infections such as E. coli and allowing scientists to create novel molecules that may provide ...

New compounds may control deadly fungal infections

An estimated 25,000 Americans develop severe fungal infections each year, leading to 10,000 deaths despite the use of anti-fungal drugs. The associated cost to the U.S. health care system has been estimated at $1 billion ...

page 18 from 29